Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients

被引：0
|
作者：
Morin, Clara [1 ,2 ]
Villeneuve, Thomas [1 ]
Norkowski, Emma [3 ]
Rosencher, Lise [4 ,5 ]
Cadranel, Jacques [4 ,5 ]
Mazieres, Julien [1 ,2 ]
机构：
[1] Univ Hosp Toulouse, Pulmonol Dept, 24 Chemin Pouvourville, F-31059 Toulouse, France
[2] Univ Toulouse III Paul Sabatier, Ctr Rech Cancerol Toulouse CRCT, Inserm, CNRS, 2 Ave Hubert Curien, F-31100 Toulouse, France
[3] Medipath, Pathol, 116 Route Espagne, F-31100 Toulouse, France
[4] Hop Tenon, AP HP, Pulmonol & Thorac Oncol Dept, 4 Rue Chine, F-75020 Paris, France
[5] Sorbonne Univ, 4 Rue Chine, F-75020 Paris, France
来源：
RESPIRATORY MEDICINE AND RESEARCH | 2024年 / 86卷
关键词：
Non-small cell lung cancer; ALK; ROS1; Targeted therapy; Drug-induced sarcoidosis-like reaction; Safety;
D O I：
10.1016/j.resmer.2024.101138
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] ALK, ROS1 and EGFR next-generation tyrosine kinase inhibitors in advanced non-small-cell lung cancer
    Winiarczyk, Kinga
    Piorek, Aleksandra
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (03): : 150 - 157
  • [42] Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors
    Verdura, Sara
    Antonio Encinar, Jose
    Teixidor, Eduard
    Segura-Carretero, Antonio
    Micol, Vicente
    Cuyas, Elisabet
    Bosch-Barrera, Joaquim
    Menendez, Javier A.
    CANCERS, 2022, 14 (24)
  • [43] Efficacy and Safety of ALK Inhibitors in ALK-Rearranged Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Breadner, D.
    Shanmuganatjan, S.
    Boldt, G.
    Blanchette, P.
    Raphael, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1034 - S1034
  • [44] ALK and ROS1 Rearrangements Tested by Fluorescence In Situ Hybridization in Cytological Smears From Advanced Non-Small Cell Lung Cancer Patients
    Bozzetti, Cecilia
    Nizzoli, Rita
    Tiseo, Marcello
    Squadrilli, Anna
    Lagrasta, Costanza
    Buti, Sebastiano
    Gasparro, Donatello
    Zanoni, Daniele
    Majori, Maria
    De Filippo, Massimo
    Mazzoni, Francesca
    Maddau, Cristina
    Naldi, Nadia
    Sammarelli, Gabriella
    Frati, Caterina
    Pinto, Carmine
    Ardizzoni, Andrea
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (11) : 941 - 946
  • [45] Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions
    Liu, Qinghua
    Huang, Qingyan
    Yu, Zhikang
    Wu, Heming
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (03) : 216 - 225
  • [46] ALK inhibitors and advanced non-small cell lung cancer (Review)
    Rossi, Antonio
    Maione, Paolo
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    Ciardiello, Fortunato
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 499 - 508
  • [47] Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma
    Zhao, Xiaoliang
    Yue, Dongsheng
    Qian, Juanjuan
    Zhang, Lei
    Song, Jin
    Zhang, Bin
    Zhang, Chunmei
    Sun, Leina
    Ma, Yuchen
    Zhang, Henghui
    Wang, Changli
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer
    Clark, Jeffrey W.
    Camidge, D. Ross
    Kwak, Eunice L.
    Maki, Robert G.
    Shapiro, Geoffrey I.
    Chen, Isan
    Tan, Weiwei
    Randolph, Sophia
    Christensen, James G.
    Ozeck, Mark
    Tang, Yiyun
    Wilner, Keith D.
    Salgia, Ravi
    FUTURE ONCOLOGY, 2020, 16 (01) : 4289 - 4301
  • [49] Optimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors
    Singh, Abhay
    Chen, Hongbin
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 6615 - 6628
  • [50] Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer
    Berradi, Hind
    Kaanane, Houda
    El Kadmiri, Nadia
    Nadifi, Sellama
    GENE REPORTS, 2018, 11 : 196 - 204
12345